GlaxoSmithKline Plc has taken the unusual step of tapping the engineering expertise of a sports car manufacturer, the McLaren Group, in order to improve the way it conducts clinical trials, and manufactures pharmaceuticals. ---Subscribe to MedNous to access this article--- Company News